PubMed COVID-19 Clinical Care

CONCLUSION: The findings revealed that fathers are fairly involved in childcare even mainly through providing necessary resources. Significantly high proportions of children were left under the care of their underage siblings leading to questions of

CONCLUSION: The survey findings have important implications for designing interventions to increase willingness and to reduce hesitancy for COVID-19 vaccine among parents of frail children aged 6 months-4 years in Italy.

CONCLUSIONS: The development and prognosis of COVID-19 may be significantly correlated with consciousness status, and the levels of neutrophils and CRP.

No abstract

The SARS-CoV-2 has infected many people globally with the ravaging COVID-19; a disease, which has become challenging for every aspect of modern healthcare. The saliva and oral mucosa are sites of high risk for increased viral loads, and aside from

CONCLUSION: Deeply phenotyped comorbidity-free young patients with critical and non-critical SARS-CoV-2 infection are characterized by a unique set of expressed RNA variants. The findings in this study can inform the patient classification process in

CONCLUSION: The COVID-19 pandemic has had a significant impact on the anxiety levels of the medical staff and the public, with the medical personnel showing a higher anxiety level than the public, especially female medical staff in Wuhan. Therefore

Controlling human mobility is thought to be an effective measure to prevent the spread of the COVID-19 pandemic. This study aims to clarify the human mobility types that impacted the number of COVID-19 cases during the medium-term COVID-19 pandemic

Fifteen years ago, Jane Guyer (2007) argued that the near future had largely disappeared from collective imaginaries, replaced by longer-term horizons associated with evangelical Christianity and free market capitalism. While not seeking to repudiate

Potent neutralizing antibodies (nAbs) against SARS-CoV-2 are a promising therapeutic against the ongoing COVID-19 pandemic. However, the continuous emergence of neutralizing antibody escape variants makes it challenging for antibody therapeutics